Review





Similar Products

polyclonal antibody against type vii collagen  (Thermo Fisher)
99
Thermo Fisher polyclonal antibody against type vii collagen
Polyclonal Antibody Against Type Vii Collagen, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antibody against type vii collagen/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
polyclonal antibody against type vii collagen - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
rabbit anti col7a1  (Proteintech)
93
Proteintech rabbit anti col7a1
Rabbit Anti Col7a1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti col7a1/product/Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti col7a1 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
p lrp6 1490  (Proteintech)
93
Proteintech p lrp6 1490
P Lrp6 1490, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p lrp6 1490/product/Proteintech
Average 93 stars, based on 1 article reviews
p lrp6 1490 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
type vii collagen antibody  (Millipore)
90
Millipore type vii collagen antibody
a , qRT-PCR analysis of HRH1 , MMP2 , and MMP9 in skin organoids at day 7, upon histamine or antihistamine and histamine treatment. Hist-histamine, CF-clemastine fumarate. Results are representative of independent experiments conducted in replicates. Two-tailed Student’s t-tests calculated the P-value by comparing Hist to control, then CF to the Hist group for each gene. Error bar-standard deviation. b , Keratin 5 (red) and type <t>VII</t> <t>collagen</t> (green) immunofluorescence of oncogenic HRAS and CDK4 -transformed human skin organoids following treatment with histamine or the P38 inhibitor SB203580. Scale bar=100μm, conducted with replicates and repeated three independent times.
Type Vii Collagen Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/type vii collagen antibody/product/Millipore
Average 90 stars, based on 1 article reviews
type vii collagen antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
col7a1 polyclonal antibody  (Proteintech)
93
Proteintech col7a1 polyclonal antibody
Identification of <t>COL7A1</t> as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).
Col7a1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col7a1 polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
col7a1 polyclonal antibody - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
type vii collagen elisa kits  (MBL Life science)
90
MBL Life science type vii collagen elisa kits
Identification of <t>COL7A1</t> as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).
Type Vii Collagen Elisa Kits, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/type vii collagen elisa kits/product/MBL Life science
Average 90 stars, based on 1 article reviews
type vii collagen elisa kits - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mouse monoclonal igg1 antibody against collagen type vii  (Merck & Co)
90
Merck & Co mouse monoclonal igg1 antibody against collagen type vii
Identification of <t>COL7A1</t> as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).
Mouse Monoclonal Igg1 Antibody Against Collagen Type Vii, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal igg1 antibody against collagen type vii/product/Merck & Co
Average 90 stars, based on 1 article reviews
mouse monoclonal igg1 antibody against collagen type vii - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
monoclonal anti-collagen type vii antibody produced in mouse, clone lh7.2 ma5-13,432  (Thermo Fisher)
90
Thermo Fisher monoclonal anti-collagen type vii antibody produced in mouse, clone lh7.2 ma5-13,432
Identification of <t>COL7A1</t> as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).
Monoclonal Anti Collagen Type Vii Antibody Produced In Mouse, Clone Lh7.2 Ma5 13,432, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-collagen type vii antibody produced in mouse, clone lh7.2 ma5-13,432/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
monoclonal anti-collagen type vii antibody produced in mouse, clone lh7.2 ma5-13,432 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
polyclonal anti collagen type vii rabbit antibody  (Thermo Fisher)
99
Thermo Fisher polyclonal anti collagen type vii rabbit antibody
Identification of <t>COL7A1</t> as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).
Polyclonal Anti Collagen Type Vii Rabbit Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal anti collagen type vii rabbit antibody/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
polyclonal anti collagen type vii rabbit antibody - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
anti collagen type vii antibody  (Thermo Fisher)
99
Thermo Fisher anti collagen type vii antibody
Identification of <t>COL7A1</t> as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).
Anti Collagen Type Vii Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti collagen type vii antibody/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
anti collagen type vii antibody - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


a , qRT-PCR analysis of HRH1 , MMP2 , and MMP9 in skin organoids at day 7, upon histamine or antihistamine and histamine treatment. Hist-histamine, CF-clemastine fumarate. Results are representative of independent experiments conducted in replicates. Two-tailed Student’s t-tests calculated the P-value by comparing Hist to control, then CF to the Hist group for each gene. Error bar-standard deviation. b , Keratin 5 (red) and type VII collagen (green) immunofluorescence of oncogenic HRAS and CDK4 -transformed human skin organoids following treatment with histamine or the P38 inhibitor SB203580. Scale bar=100μm, conducted with replicates and repeated three independent times.

Journal: bioRxiv

Article Title: Epithelial tumor cells utilize mast cell-derived histamine to regulate perineural invasion

doi: 10.1101/2025.06.23.661147

Figure Lengend Snippet: a , qRT-PCR analysis of HRH1 , MMP2 , and MMP9 in skin organoids at day 7, upon histamine or antihistamine and histamine treatment. Hist-histamine, CF-clemastine fumarate. Results are representative of independent experiments conducted in replicates. Two-tailed Student’s t-tests calculated the P-value by comparing Hist to control, then CF to the Hist group for each gene. Error bar-standard deviation. b , Keratin 5 (red) and type VII collagen (green) immunofluorescence of oncogenic HRAS and CDK4 -transformed human skin organoids following treatment with histamine or the P38 inhibitor SB203580. Scale bar=100μm, conducted with replicates and repeated three independent times.

Article Snippet: Primary antibodies used were keratin 5 (rabbit, 1:500, BioLegend), type VII collagen (mouse, 1:250, Millipore Sigma), and type IV collagen (rabbit, 1:100, Abcam).

Techniques: Quantitative RT-PCR, Two Tailed Test, Control, Standard Deviation, Immunofluorescence, Transformation Assay

Identification of COL7A1 as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).

Journal: Frontiers in Pharmacology

Article Title: COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma

doi: 10.3389/fphar.2025.1543193

Figure Lengend Snippet: Identification of COL7A1 as a BM-related key biomarker in LUAD. (A) Univariate Cox regression analysis of 12 candidate genes. (B–D) The expression levels of three prognosis-associated genes, including COL7A1 (B) , MMP1 (C) , and LAMA3 (D) , in LUAD samples and controls of the TCGA dataset (*p < 0.05, **p < 0.01, ***p < 0.001).

Article Snippet: In this experiment, the primary antibody was COL7A1 Polyclonal Antibody (19799-1-AP, Proteintech Group, Wuhan, China) and GAPDH Antibody (60004-1-Ig, Proteintech Group, Wuhan, China), and the secondary antibody was horseradase labeling of goat with anti-rabbit IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China) and horseradase labeling of goat anti-mouse IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China).

Techniques: Biomarker Assay, Expressing

Validation of the COL7A1 expression levels. (A–C) Box plot of COL7A1 expression in LUAD and controls of GSE115002 (A) , GSE11072 (B) cohorts, and CCLE database (C) . (D) Immunohistochemical plots of COL7A1 in lung tissue downloaded from the HPA database, with LUAD tissue on the left and normal lung tissue on the right. (E, F) Expression of COL7A1 in LUAD determined by qPCR (E) and Western blot (F) . (*p < 0.05, **p < 0.01, ***p < 0.001).

Journal: Frontiers in Pharmacology

Article Title: COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma

doi: 10.3389/fphar.2025.1543193

Figure Lengend Snippet: Validation of the COL7A1 expression levels. (A–C) Box plot of COL7A1 expression in LUAD and controls of GSE115002 (A) , GSE11072 (B) cohorts, and CCLE database (C) . (D) Immunohistochemical plots of COL7A1 in lung tissue downloaded from the HPA database, with LUAD tissue on the left and normal lung tissue on the right. (E, F) Expression of COL7A1 in LUAD determined by qPCR (E) and Western blot (F) . (*p < 0.05, **p < 0.01, ***p < 0.001).

Article Snippet: In this experiment, the primary antibody was COL7A1 Polyclonal Antibody (19799-1-AP, Proteintech Group, Wuhan, China) and GAPDH Antibody (60004-1-Ig, Proteintech Group, Wuhan, China), and the secondary antibody was horseradase labeling of goat with anti-rabbit IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China) and horseradase labeling of goat anti-mouse IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China).

Techniques: Expressing, Immunohistochemical staining, Western Blot

Exploration of the association of COL7A1 expression with prognosis of LUAD patients. (A–C) The Kaplan-Meier curves of COL7A1 high expression and COL7A1 low expression groups in the LUAD patients of TCGA (A) , GSE72094 (B) , and GSE68465 (C) datasets. (D–F) Time-dependent ROC curves of the COL7A1 expression for predicting 1-, 3-, and 5-year survival in the TCGA (D) , GSE72094 (E) , and GSE68465 (F) datasets. (G) Univariate and multivariate Cox regression analysis of COL7A1 expression and clinical features including age, gender, clinical stage, and race.

Journal: Frontiers in Pharmacology

Article Title: COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma

doi: 10.3389/fphar.2025.1543193

Figure Lengend Snippet: Exploration of the association of COL7A1 expression with prognosis of LUAD patients. (A–C) The Kaplan-Meier curves of COL7A1 high expression and COL7A1 low expression groups in the LUAD patients of TCGA (A) , GSE72094 (B) , and GSE68465 (C) datasets. (D–F) Time-dependent ROC curves of the COL7A1 expression for predicting 1-, 3-, and 5-year survival in the TCGA (D) , GSE72094 (E) , and GSE68465 (F) datasets. (G) Univariate and multivariate Cox regression analysis of COL7A1 expression and clinical features including age, gender, clinical stage, and race.

Article Snippet: In this experiment, the primary antibody was COL7A1 Polyclonal Antibody (19799-1-AP, Proteintech Group, Wuhan, China) and GAPDH Antibody (60004-1-Ig, Proteintech Group, Wuhan, China), and the secondary antibody was horseradase labeling of goat with anti-rabbit IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China) and horseradase labeling of goat anti-mouse IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China).

Techniques: Expressing

Exploration of the biological significance of different COL7A1 expression groups. (A) The top 10 KEGG pathways with significant differences between the high COL7A1 expression and low COL7A1 expression groups. (B) Five important KEGG pathways were activated in the high COL7A1 expression group based on GSEA. (C) The top 5 GO terms with significant differences between the high COL7A1 expression and low COL7A1 expression groups. (D) Five important GO terms were activated in the high COL7A1 expression group based on GSEA.

Journal: Frontiers in Pharmacology

Article Title: COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma

doi: 10.3389/fphar.2025.1543193

Figure Lengend Snippet: Exploration of the biological significance of different COL7A1 expression groups. (A) The top 10 KEGG pathways with significant differences between the high COL7A1 expression and low COL7A1 expression groups. (B) Five important KEGG pathways were activated in the high COL7A1 expression group based on GSEA. (C) The top 5 GO terms with significant differences between the high COL7A1 expression and low COL7A1 expression groups. (D) Five important GO terms were activated in the high COL7A1 expression group based on GSEA.

Article Snippet: In this experiment, the primary antibody was COL7A1 Polyclonal Antibody (19799-1-AP, Proteintech Group, Wuhan, China) and GAPDH Antibody (60004-1-Ig, Proteintech Group, Wuhan, China), and the secondary antibody was horseradase labeling of goat with anti-rabbit IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China) and horseradase labeling of goat anti-mouse IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China).

Techniques: Expressing

The landscape of immune cell infiltration between different groups. (A–D) Box plot of tumor purity (A) , immune (B) , stromal (C) , and ESTIMATE (D) scores in different COL7A1 expression groups based on the GSE68465 dataset. (E, F) TStacked plot of 22 immune cell types in each sample of TCGA-LUAD (E) and GSE68465 (F) cohorts. (G, H) The 22 immune cell infiltration in the high COL7A1 expression and low COL7A1 expression groups of TCGA-LUAD (G) and GSE68465 (H) cohorts. (*p < 0.05, **p < 0.01, ***p < 0.001)

Journal: Frontiers in Pharmacology

Article Title: COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma

doi: 10.3389/fphar.2025.1543193

Figure Lengend Snippet: The landscape of immune cell infiltration between different groups. (A–D) Box plot of tumor purity (A) , immune (B) , stromal (C) , and ESTIMATE (D) scores in different COL7A1 expression groups based on the GSE68465 dataset. (E, F) TStacked plot of 22 immune cell types in each sample of TCGA-LUAD (E) and GSE68465 (F) cohorts. (G, H) The 22 immune cell infiltration in the high COL7A1 expression and low COL7A1 expression groups of TCGA-LUAD (G) and GSE68465 (H) cohorts. (*p < 0.05, **p < 0.01, ***p < 0.001)

Article Snippet: In this experiment, the primary antibody was COL7A1 Polyclonal Antibody (19799-1-AP, Proteintech Group, Wuhan, China) and GAPDH Antibody (60004-1-Ig, Proteintech Group, Wuhan, China), and the secondary antibody was horseradase labeling of goat with anti-rabbit IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China) and horseradase labeling of goat anti-mouse IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China).

Techniques: Expressing

Validation of COL7A1 expression in predicting the clinical benefit of immunotherapy. (A) IC50 values of the 11 drugs in the COL7A1-H and COL7A1-L groups. (B) The expression levels of immune checkpoint genes in different COL7A1 expression groups. (C) . Correlation analysis of immune checkpoint genes and COL7A1 expression (the data conformed to normal distribution, employing pearson correlation analysis) (D–I) Violin plots of TIDE (D) , Exclusion (E) , Dysfunction (F) , MDSC (G) , CAF (H) , and CD274 (I) scores in different COL7A1 expression groups.

Journal: Frontiers in Pharmacology

Article Title: COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma

doi: 10.3389/fphar.2025.1543193

Figure Lengend Snippet: Validation of COL7A1 expression in predicting the clinical benefit of immunotherapy. (A) IC50 values of the 11 drugs in the COL7A1-H and COL7A1-L groups. (B) The expression levels of immune checkpoint genes in different COL7A1 expression groups. (C) . Correlation analysis of immune checkpoint genes and COL7A1 expression (the data conformed to normal distribution, employing pearson correlation analysis) (D–I) Violin plots of TIDE (D) , Exclusion (E) , Dysfunction (F) , MDSC (G) , CAF (H) , and CD274 (I) scores in different COL7A1 expression groups.

Article Snippet: In this experiment, the primary antibody was COL7A1 Polyclonal Antibody (19799-1-AP, Proteintech Group, Wuhan, China) and GAPDH Antibody (60004-1-Ig, Proteintech Group, Wuhan, China), and the secondary antibody was horseradase labeling of goat with anti-rabbit IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China) and horseradase labeling of goat anti-mouse IgG 1:1,000 (ZB-2301-0.1mL, Beijing Zhong Shan-Golden Bridge Biological Technology Co., Ltd., Beijing, China).

Techniques: Expressing